Filing Details
- Accession Number:
- 0001179110-17-010741
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-07-27 17:03:15
- Reporting Period:
- 2017-07-25
- Filing Date:
- 2017-07-27
- Accepted Time:
- 2017-07-27 17:03:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1800 | Abbott Laboratories | ABT | Pharmaceutical Preparations (2834) | 360698440 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1565916 | L Hubert Allen | 100 Abbott Park Road Abbott Park IL 60064-6400 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Shares Without Par Value | Acquisiton | 2017-07-25 | 4,600 | $26.70 | 105,479 | No | 4 | M | Direct | |
Common Shares Without Par Value | Disposition | 2017-07-25 | 2,600 | $50.80 | 102,879 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2017-07-25 | 1,800 | $50.79 | 101,079 | No | 4 | S | Direct | |
Common Shares Without Par Value | Disposition | 2017-07-25 | 200 | $50.79 | 100,879 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Shares | Option (right to buy) | Disposition | 2017-07-25 | 4,600 | $0.00 | 4,600 | $26.70 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2011-02-15 | 2018-02-14 | No | 4 | M | Direct |
Footnotes
- Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.